Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived stem cell therapy for post-prostatectomy stress urinary incontinence
jRCTb030220456Completed
- Sponsor
- Medical Data Vision
- Start
- Nov 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous adipose-derived mesenchymal stromal cells in stress urinary incontinence (SUI) (2 arms), sponsored by Medical Data Vision. Primary endpoint: Occurrence rate of adverse events. Started Nov 2022; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on jRCTb030220456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb030220456.